Chondrocyte Therapy – Cartilage Regeneration Explained
Chondrocyte therapy is a biological procedure for treating cartilage defects, in which the patient´s own cartilage cells are cultivated in a lab and reimplanted into the damaged joint.
Things worth knowing about "Chondrocyte Therapy"
Chondrocyte therapy is a biological procedure for treating cartilage defects, in which the patient´s own cartilage cells are cultivated in a lab and reimplanted into the damaged joint.
What is Chondrocyte Therapy?
Chondrocyte therapy, also known as autologous chondrocyte implantation (ACI), is a biological treatment method for cartilage defects, particularly in the knee joint. The procedure involves harvesting cartilage cells (chondrocytes) from the patient, expanding them in a laboratory setting, and then reimplanting them into the damaged area of the joint. The goal is to replace defective cartilage tissue with newly formed, functional tissue, thereby reducing pain and preserving long-term joint function.
When is Chondrocyte Therapy Used?
Chondrocyte therapy is primarily indicated for well-defined, deep cartilage defects caused by sports injuries, trauma, or degenerative changes. Common indications include:
- Focal cartilage defects of the knee joint (Grade III and IV according to the ICRS classification)
- Osteochondritis dissecans (detachment of cartilage-bone fragments)
- Traumatic cartilage damage in younger, physically active patients
- Failed previous cartilage repair procedures
It is important to note that this therapy is generally most suitable for patients who have not yet developed generalized osteoarthritis (widespread joint degeneration).
How Does Chondrocyte Therapy Work?
Step 1: Cartilage Cell Harvesting
In a first arthroscopic procedure, the surgeon removes a small sample of healthy cartilage from a low-load-bearing area of the affected joint. This sample is then sent to a specialized laboratory.
Step 2: Cell Cultivation in the Laboratory
In the laboratory, the harvested chondrocytes are cultured and multiplied under controlled conditions over a period of several weeks (typically 4 to 6 weeks). Depending on the technique, the cells are cultivated either in suspension (liquid form) or embedded in a biodegradable scaffold material. The latter approach is referred to as matrix-associated autologous chondrocyte implantation (MACI).
Step 3: Reimplantation
In a second surgical procedure, the expanded chondrocytes are introduced into the cartilage defect. In classical ACI, the cells are secured beneath a periosteal flap (a patch of bone membrane) or a collagen membrane. In MACI, the scaffold material containing the integrated cells is shaped to fit the defect and fixed in place.
Types of Chondrocyte Therapy
- Autologous Chondrocyte Implantation (ACI): The classical technique using cell injection beneath a membrane.
- Matrix-Associated Autologous Chondrocyte Implantation (MACI): A more modern approach using cells embedded in a scaffold, often performable arthroscopically.
- Allogeneic Chondrocyte Therapy: Use of donor cells (less common, still under clinical investigation).
Recovery and Aftercare
Rehabilitation following chondrocyte therapy is a lengthy process requiring patience and commitment. Full weight-bearing capacity of the joint is typically not achieved until 12 to 18 months after the procedure. Typical phases of aftercare include:
- Phase 1 (0–6 weeks): Joint offloading, physiotherapy to improve range of motion.
- Phase 2 (6–12 weeks): Gradual increase in weight-bearing, muscle strengthening exercises.
- Phase 3 (3–12 months): Functional training, gradual return to sports activities.
Outcomes and Risks
Studies demonstrate that chondrocyte therapy leads to significant improvements in joint function and notable pain reduction in suitable patients. Long-term results spanning 10 to 15 years confirm the durability of the cartilage repair in the majority of treated patients.
Possible risks and complications include:
- Infection or inflammation within the joint
- Rejection reactions (particularly with allogeneic procedures)
- Incomplete cartilage integration (graft failure)
- Scarring or adhesions
- Re-injury of cartilage due to premature loading
References
- Brittberg M. et al. - Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England Journal of Medicine, 1994;331(14):889-895.
- Widuchowski W. et al. - Articular cartilage defects: study in 25,124 knee arthroscopies. The Knee, 2007;14(3):177-182.
- Kon E. et al. - ACI and MACI for cartilage repair of the knee: a systematic review. Knee Surgery, Sports Traumatology, Arthroscopy, 2021;29(9):2811-2830.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMigraine aura
Filoviridae
Bundibugyo ebolavirus
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Chondrocyte Therapy-en